Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | POU3F4 | FIMM | pan-cancer | AAC | -0.47 | 0.005 |
mRNA | KPNB1 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | CKS2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | RP11-214K3.25 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | UTRN | FIMM | pan-cancer | AAC | 0.49 | 0.005 |
mRNA | ZNF530 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
mRNA | CX3CL1 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
mRNA | MARK2 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
mRNA | CHRM4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | SEMA6D | CCLE | pan-cancer | AAC | -0.14 | 0.005 |